SCHEMBL19700174

SCHEMBL19700174

CNc1ccc([N+](=O)[O-])c(N)c1C

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 1/20 0.45
HTT P42858 1/20 0.43
TDP1 Q9NUW8 2/20 0.42
MAPT P10636 6/20 0.42
KMT2A Q03164 1/20 0.42
ALDH1A1 P00352 3/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41
TSHR P16473 5/20 0.41
CYP3A4 P08684 2/20 0.41
RECQL P46063 1/20 0.41
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CDC25B P30305 1/20 0.38
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21461475 0.77 TDP1 (0.47) HCAR3HTTTDP1MAPTKMT2A
SCHEMBL2056814 0.77 TSHR (0.60) TDP1MAPTKMT2AALDH1A1TSHR
SCHEMBL2656793 0.77 TSHR (0.55) TDP1MAPTKMT2AALDH1A1CYP1A2
SCHEMBL6142555 0.76 TDP1 (0.48) HCAR3HTTTDP1MAPTKMT2A
SCHEMBL9500164 0.76 TDP1 (0.48) HCAR3TDP1MAPTKMT2AALDH1A1
SCHEMBL19700169 0.76 MAPT (0.56) HTTTDP1MAPTKMT2AALDH1A1
SCHEMBL1072166 0.74 HCAR3 (0.46) HCAR3HTTTDP1MAPTKMT2A
SCHEMBL17847162 0.74 TDP1 (0.67) TDP1MAPTKMT2AALDH1A1CYP1A2
SCHEMBL5510180 0.74 TDP1 (0.52) TDP1KMT2AALDH1A1TSHRCYP3A4
SCHEMBL31569017 0.74 TDP1 (0.52) TDP1KMT2AALDH1A1TSHRCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858900-B2 Fluorinated 2-amino-4-(substituted amino)phenyl carbamate derivatives OCUTERRA THERAPEUTICS, INC. (US) 2024-01-02 US disclosed
US-20170355679-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES SCIFLUOR LIFE SCIENCES, INC. 2017-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170355679-A1 FLUORINATED 2-AMINO-4-(SUBSTITUTED AMINO)PHENYL CARBAMATE DERIVATIVES KCNQ2, KCNQ1, KCNQ3 HCAR3 532/4885HTT 1584/4885TDP1 3295/4885
US-11858900-B2 Fluorinated 2-amino-4-(substituted amino)phenyl carbamate derivatives KCNQ2, KCNQ1, KCNQ3 HCAR3 532/4885HTT 1584/4885TDP1 3295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.